Top Markets
#1 Songbird Songbird +15.68%
#2 TENDIES TENDIES +9.42%
#3 DAPPOS DAPPOS +9.36%
#4 pipedog pipedog +8.37%
#5 Prom Prom +7.95%
#6 Helium Helium +7.35%
#7 Collector Crypt Collector Crypt +6.69%
#8 MarsCoin MarsCoin +6.62%
#9 Cryptopia Cryptopia +5.90%
#10 Moolah Moolah +5.25%
Coin of the day
Songbird Songbird
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
MedPlus Health Services Limited MedPlus Health Services Limited

MedPlus Health Services Limited

MEDPLUS
Kedudukan dalam Saham #10055
MedPlus Health Services Limited operates primarily as an Indian retailer of... MedPlus Health Services Limited operates primarily as an Indian retailer of pharmaceutical products and diverse general merchandise. Its extensive product catalog includes vital health and wellness items such as prescription medications, vitamins, medical equipment, and diagnostic kits, alongside everyday essentials like toiletries, baby care products, cleaning supplies, and sanitizers. Beyond its retail footprint, the company also offers wholesale cash-and-carry services, comprehensive pathological laboratory testing, and contract manufacturing for its own-brand pharmaceutical goods. By March 31, 2021, MedPlus had established a substantial presence with 1,659 brick-and-mortar stores situated in the Indian states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, complemented by its online store. This Hyderabad-based company was incorporated in 2006.
Harga Saham
$7.46
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$896.69M
Perubahan (1 hari)
-1.74%
Perubahan (1 tahun)
-21.84%
Negara
IN
Perdagangan MedPlus Health Services Limited (MEDPLUS)

Kategori

Healthcare
Pendapatan untuk MedPlus Health Services Limited (MEDPLUS)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini MedPlus Health Services Limited, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi MedPlus Health Services Limited dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT